Person

Silji Abraham

Formerly SVP, Chief Technology Officer, West Pharmaceutical Services

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$12.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 12, 2024WSTSale1,800$330.78$595K
Feb 23, 2024WSTSale7,012$365.00$2.6M
Aug 8, 2023WSTSale6$397.69$2K
Aug 8, 2023WSTSale8,154$397.18$3.2M
May 1, 2023WSTSale649$366.14$238K
May 1, 2023WSTSale7,371$365.55$2.7M
Mar 9, 2023WSTSale1,500$322.57$484K
Aug 1, 2022WSTSale5,374$343.93$1.8M
May 10, 2021WSTSale2,171$335.00$727K
May 11, 2020WSTSale1,000$204.50$205K
May 8, 2020WSTSale1,000$200.00$200K
Apr 28, 2020WSTSale500$200.66$100K

SEC reporting-owner ID (CIK) 1733001 · all filings on EDGAR

Silji Abraham | USBoard